Literature DB >> 11668677

The eyeless mouse mutation (ey1) removes an alternative start codon from the Rx/rax homeobox gene.

P Tucker1, L Laemle, A Munson, S Kanekar, E R Oliver, N Brown, H Schlecht, M Vetter, T Glaser.   

Abstract

The eyeless inbred mouse strain ZRDCT has long served as a spontaneous model for human anophthalmia and the evolutionary reduction of eyes that has occurred in some naturally blind mammals. ZRDCT mice have orbits but lack eyes and optic tracts and have hypothalamic abnormalities. Segregation data suggest that a small number of interacting genes are responsible, including at least one major recessive locus, ey1. Although predicted since the 1940s, these loci were never identified. We mapped ey1 to chromosome 18 using an F2 genome scan and there found a Met10-->Leu mutation in Rx/rax, a homeobox gene that is expressed in the anterior headfold, developing retina, pineal, and hypothalamus and is translated via a leaky scanning mechanism. The mutation affects a conserved AUG codon that functions as an alternative translation initiation site and consequently reduces the abundance of Rx protein. In contrast to a targeted Rx null allele, which causes anophthalmia, central nervous system defects, and neonatal death, the hypomorphic M10L allele is fully viable. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11668677     DOI: 10.1002/gene.10003

Source DB:  PubMed          Journal:  Genesis        ISSN: 1526-954X            Impact factor:   2.487


  29 in total

1.  Loss of photic entrainment and altered free-running circadian rhythms in math5-/- mice.

Authors:  Raymond Wee; Ana Maria Castrucci; Ignacio Provencio; Lin Gan; Russell N Van Gelder
Journal:  J Neurosci       Date:  2002-12-01       Impact factor: 6.167

2.  Systematic characterization of the zinc-finger-containing proteins in the mouse transcriptome.

Authors:  Timothy Ravasi; Thomas Huber; Mihaela Zavolan; Alistair Forrest; Terry Gaasterland; Sean Grimmond; David A Hume
Journal:  Genome Res       Date:  2003-06       Impact factor: 9.043

3.  Specification of the retinal fate of mouse embryonic stem cells by ectopic expression of Rx/rax, a homeobox gene.

Authors:  Yoko Tabata; Yasuo Ouchi; Haruyuki Kamiya; Toshiya Manabe; Ken-ichi Arai; Sumiko Watanabe
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

Review 4.  Conserved genetic pathways associated with microphthalmia, anophthalmia, and coloboma.

Authors:  Linda M Reis; Elena V Semina
Journal:  Birth Defects Res C Embryo Today       Date:  2015-06-03

5.  Subcortical functional reorganization due to early blindness.

Authors:  Gaelle S L Coullon; Fang Jiang; Ione Fine; Kate E Watkins; Holly Bridge
Journal:  J Neurophysiol       Date:  2015-02-11       Impact factor: 2.714

6.  Aberrant development of the suprachiasmatic nucleus and circadian rhythms in mice lacking the homeodomain protein Six6.

Authors:  Daniel D Clark; Michael R Gorman; Megumi Hatori; Jason D Meadows; Satchidananda Panda; Pamela L Mellon
Journal:  J Biol Rhythms       Date:  2013-02       Impact factor: 3.182

7.  Pax6 regulation of Math5 during mouse retinal neurogenesis.

Authors:  Amy N Riesenberg; Tien T Le; Minde I Willardsen; David C Blackburn; Monica L Vetter; Nadean L Brown
Journal:  Genesis       Date:  2009-03       Impact factor: 2.487

Review 8.  Eye development and retinogenesis.

Authors:  Whitney Heavner; Larysa Pevny
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-12-01       Impact factor: 10.005

9.  Confirmation of RAX gene involvement in human anophthalmia.

Authors:  L Lequeux; M Rio; A Vigouroux; M Titeux; H Etchevers; F Malecaze; N Chassaing; P Calvas
Journal:  Clin Genet       Date:  2008-09-09       Impact factor: 4.438

10.  Rax is a selector gene for mediobasal hypothalamic cell types.

Authors:  Fuqu Lu; Deepon Kar; Nicole Gruenig; Zi Wei Zhang; Nicole Cousins; Helen M Rodgers; Eric C Swindell; Milan Jamrich; Carol Schuurmans; Peter H Mathers; Deborah M Kurrasch
Journal:  J Neurosci       Date:  2013-01-02       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.